List of Imaging Companies in Sweden - 3
Search through the full list with powerful filtering options
Want this in Excel? Get Quote NowCompany | About |
---|---|
Ascelia Pharma AB Hyllie Boulevard 34, Malmö, Skane County 215 32, SE | Ascelia Pharma is a biotech company focused on orphan oncology treatments. We develop and commercialize novel drugs that address unmet medical needs and have a clear development and market pathway. The company has two drug candidates – Orviglance® (former working name Mangoral) and Oncoral – in clinical development. Ascelia Pharma has global headquarters in Malmö, Sweden, and is listed on Nasdaq Stockholm (ticker: ACE). About Orviglance (Mangoral) Orviglance* (manganese chloride tetrahydrate) is a novel oral contrast agent for MR-imaging developed to improve the detection and visualization of focal liver lesions (including liver metastases and primary tumors) in patients with reduced kidney function. These patients are at risk of serious side effects from the currently available class of gadolinium-based contrast agents. Orviglance, which has been granted an Orphan Drug Designation by the US Food and Drug Administration (FDA), is currently in Phase 3 development, including the global multi-center SPARKLE study. About Oncoral Oncoral is a novel oral irinotecan tablet in development. Irinotecan is a chemotherapy with established potent anti-tumor effect – even in difficult to treat cancers. Oncoral is a daily tablet with the potential to offer better patient outcomes with improved safety following a daily tablet treatment compared to intravenous high-dose infusions at the hospital. Oncoral is initially developed for the treatment of gastric cancer, a cancer form with unmet needs and the opportunity for Orphan Drug status in the US and Europe. Following successful Phase 1 results, Phase 2 clinical development for Oncoral is in preparation. *Trademark is registered in Europe and several other markets and submitted for registration in the US. |
Lumito AB Mårtenstorget 5, Lund, Skåne län, SE, 223 51 | We specialise in medical technology for digital pathology and aim to improve tissue diagnostics with our patented technology. With technology based on up-converted nanoparticles (UCNP), high-quality images are generated with increased contrast and decreased irrelevant background noise. These images shorten turnaround time and provide higher-quality data for analysis. Lumito is a spin-off from a research team at Lund University's Division of Atomic Physics and Laser Centre and is planning to launch its product SCIZYS for research laboratories initially. |
Perimed AB järfälla, stockholms län, sweden | Perimed AB is a Swedish company, founded in 1981 and headquartered just outside Stockholm. Perimed develops, manufactures and markets state-of-the-art diagnostic equipment to assess microcirculation and peripheral perfusion as well as Peripheral Arterial Disease. We offer solutions for clinical use as well as for research. We have more than 40 years of experience and unique competence in fiber optics, laser and camera optics, as well as tissue optics making Perimed a leader in measuring and assessing microcirculation and peripheral macro circulation. Perimed is a global company with subsidiaries in USA, China, France, Italy and Germany. Our customers in the other countries are supported either directly from our Swedish headquarters or by our certified local distributors listed on our contacts pages. |